US 11529381
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
granted A61KA61K35/745A61K9/0043
Quick answer
US patent 11529381 (Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection) held by PrecisionBiotics Group Limited expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrecisionBiotics Group Limited
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K35/745, A61K9/0043, A61P, A61P11/00